Trademark Overview
On Friday, January 2, 2026, a trademark application was filed for PROVIA with the United States Patent and Trademark Office. The USPTO has given the PROVIA trademark a serial number of 99575283. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, January 2, 2026. This trademark is owned by MiMedx Group, Inc.. The PROVIA trademark is filed in the Pharmaceutical Products category with the following description:
Human biological amniotic membrane tissue intended for subsequent implantation; biologic drugs for treating inflammation and pain using regenerative tissue components; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a micronized powder comprising amniotic material for medical purposes; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material
